Chairman’s Address to the Annual General Meeting
May 27, 2021
The transcript of the chairman’s address to the Annual General Meeting of Shareholders, for the financial year ending December 2020, is now available. Please click
Category: Investor updates
First Patient Enrolled in Phase I MagSense® HER2+ Breast Cancer Study
May 25, 2021
This week Imagion Biosystems has announced we have enrolled our first patient into our first clinical study. This is an important step for our Phase
IBX Secures Additional Capital — Shareholders Exercise Options
May 10, 2021
Imagion Biosystems announced on 10 May 2021 that it has received a total of $44,545.32 for the exercise of options. The total was composed of
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
May 10, 2021
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 10 May, 2021. Please click to review the
Imagion Biosystems and Patrys Limited to Collaborate on Brain Tumor Imaging
May 2, 2021
Imagion Biosystems is pleased to announce a partnership with the ASX-listed therapeutic antibody development company Patrys Limited. The collaborative research program aims to combine Imagion Biosystems
Quarterly Activity Report — Period ending 31 March 2021
April 29, 2021
Imagion Biosystems is pleased to report that we closed the first quarter of FY2021 maintaining a strong cash balance and having added a new study
IBX Secures Additional Capital — Shareholders Exercise Options
April 26, 2021
Imagion Biosystems announced on ASX that it has received a total of $164,754 for the exercise of options. Please click to review the full announcement
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
April 26, 2021
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on April 26, 2021. Please click to review the
IBX Secures Additional Capital — Shareholders Exercise Options
April 13, 2021
Imagion Biosystems announced on ASX that it has received a total of $81,256.85 for the exercise of options. Please click to review the full announcement
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
April 13, 2021
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on April 13, 2021. Please click to review the